Loading clinical trials...
Loading clinical trials...
The objectives of this study is to assess the safety, tolerability, and pharmacokinetics of blind, escalating, single, oral doses of ABT-333 under nonfasting conditions in healthy male adult in Japan.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Abbott
Collaborators
NCT01288417 · HIV Infections, HCV Infections
NCT01470690 · HCV Infections, Gastric Acid-related Disorders
Site Reference ID/Investigator# 19102
Kagoshima
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions